Abstract

BackgroundGastric cancer is the fifth most common cancer worldwide, with an incidence of 6.72 per 100,000 people. Thirty-two percent of gastric cancer patients will live 5 years after diagnosis. Single-site metastasis is noted in 26% of patients with gastric cancer, most commonly in the liver (48%), peritoneum (32%), lung (15%), and bone (12%). Here, a case is presented in which a single skeletal muscle metastasis appeared after appropriate resection and treatment.Case presentationA 63-year-old man underwent neoadjuvant chemotherapy and a multivisceral en bloc R0 resection. Final pathology showed no evidence of lymph node metastasis with 31 negative lymph nodes. Four months postoperatively, the patient was found to have a rapidly growing biopsy-proven extremity soft tissue gastric metastasis within the brachioradialis muscle. He subsequently underwent metastasectomy and immunotherapy.ConclusionThis case is a rare example of an isolated extremity metastasis of gastric adenocarcinoma in the setting of an R0 resection of the primary tumor and negative nodal disease on final pathology, suggestive of hematogenous spread. We review the biology, workup, and management of gastric cancer and highlight new advancements in the treatment of this aggressive cancer.

Highlights

  • Gastric cancer is the fifth most common cancer worldwide, with an incidence of 6.72 per 100,000 people

  • Of all patients with gastric adenocarcinoma, it is estimated that 26% have single-site metastasis, and 13% have multi-site

  • We report the case of a 63-year-old male who presented with a poorly differentiated gastric adenocarcinoma, underwent a staging laparoscopy with peritoneal lavage, received neoadjuvant FLOT chemotherapy, underwent a technically successful Microscopically margin-negative resection (R0) resection with Lymphadectomy harvesting hepatic (D2) lymphadenectomy, and developed an isolated

Read more

Summary

Conclusion

This case is a rare example of an isolated extremity metastasis of gastric adenocarcinoma in the setting of an R0 resection of the primary tumor and negative nodal disease on final pathology, suggestive of hematogenous spread. Workup, and management of gastric cancer and highlight new advancements in the treatment of this aggressive cancer

Background
Findings
Discussion and conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call